Edition:
United States

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

82.62USD
24 Mar 2017
Change (% chg)

$6.54 (+8.60%)
Prev Close
$76.08
Open
$78.82
Day's High
$84.30
Day's Low
$78.80
Volume
462,196
Avg. Vol
423,493
52-wk High
$96.27
52-wk Low
$57.85

Latest Key Developments (Source: Significant Developments)

Dexcom Inc says committed to borrow $75 mln in principal amount under its existing $200 mln revolving credit facility - SEC filing
Monday, 6 Mar 2017 09:20am EST 

Dexcom Inc : Dexcom Inc - on February 28, 2017, co committed to borrow $75 million in principal amount under its existing $200 million revolving credit facility - SEC filing . Dexcom Inc - borrowed funds were received by Dexcom on March 3, 2017 .Dexcom Inc - term of borrowing is six months and total interest anticipated on borrowing during that period is approximately $1.2 million.  Full Article

Dexcom Q4 gaap loss per share $0.09
Tuesday, 28 Feb 2017 04:01pm EST 

Dexcom Inc : Dexcom, inc. Reports fourth quarter and fiscal year 2016 financial results . Q4 gaap loss per share $0.09 . Q4 revenue $171.2 million versus i/b/e/s view $168 million .Q4 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

Dexcom says chief financial officer to resign, effective as of April 1
Tuesday, 21 Feb 2017 09:12am EST 

Dexcom Inc : Dexcom Inc- on Feb 14 Jess Roper, chief financial officer notified Dexcom of his decision to resign, effective as of April 1, 2017 - sec filing .Dexcom Inc - upon Roper's resignation, Dexcom will appoint Kevin Sun, as interim chief financial officer.  Full Article

Baillie Gifford & Co reports 7.25% passive stake in Dexcom Inc as of Dec 31, 2016
Friday, 20 Jan 2017 10:49am EST 

Baillie Gifford & Co:Reports 7.25 percent passive stake in Dexcom Inc as of 31 December 2016 - SEC filing.  Full Article

Dexcom reports record preliminary, unaudited revenue for the Q4 and fiscal year 2016
Tuesday, 10 Jan 2017 08:30am EST 

Dexcom Inc : Dexcom reports record preliminary, unaudited revenue for the fourth quarter and fiscal year 2016 and provides initial 2017 outlook . Sees FY 2017 revenue $710 million to $740 million . Q4 revenue $168 million versus I/B/E/S view $167.5 million . Sees FY 2016 revenue up 42 percent . Sees FY 2016 revenue $570 million . Gross margin is expected to range from 67 pct to 70 pct for 2017 . 2017 operating expenses are anticipated to increase by approximately 20 pct to 25 pct over 2016 .At end of 2017, company is targeting a patient base of 270,000 worldwide.  Full Article

U.S. FDA expands approved use of Dexcom’s G5 mobile continuous glucose monitoring system
Tuesday, 20 Dec 2016 02:53pm EST 

U.S. Food and Drug Administration : The u.s. Fda expands approved use of dexcom’s g5 mobile continuous glucose monitoring system . u.s. Fda - fda expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions Further company coverage: [DXCM.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Dexcom Inc Reports second quarter 2016 financial results
Tuesday, 2 Aug 2016 04:01pm EDT 

Dexcom Inc : Q2 revenue $137.3 million versus I/B/E/S view $132.6 million . Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S . Dexcom, Inc. Reports second quarter 2016 financial results .Q2 GAAP loss per share $0.24.  Full Article

Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting
Tuesday, 19 Jul 2016 08:32am EDT 

Dexcom Inc : Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting .Dexcom Inc says clinical chemistry and clinical toxicology devices panel to convene on July 21.  Full Article

Dexcom to expand manufacturing operations to Greater Phoenix
Monday, 20 Jun 2016 08:10am EDT 

Dexcom Inc : Dexcom to expand manufacturing operations to Greater Phoenix, Arizona .Dexcom Inc says expect initial manufacturing operations in facility to commence in Q2 of 2017.  Full Article

Dexcom says entered into $200 mln revolving credit agreement
Monday, 20 Jun 2016 06:06am EDT 

Dexcom Inc : On june 17, entered into $200 million revolving credit agreement with jpmorgan chase bank, n.a., bank of america, silicon valley bank,union bank . Says as Of June 17, 2016, Dexcom had no outstanding loans under credit agreement - Sec filing . Credit agreement provides a subfacility of up to $10 million for letters of credit . Dexcom inc says credit agreement matures on june 17, 2021 . Credit agreement provides a $25 million sublimit for borrowings in canadian dollars, euros, british pounds, swedish krona, japanese yen .Has option to increase maximum principal amount available under credit agreement by up to an additional $100 million.  Full Article

More From Around the Web

BRIEF-DexCom appoints Richard Collins to board of directors

* DexCom appoints Richard Collins to board of directors Source text for Eikon: Further company coverage: